QIAGEN partners with U.K. to expand biomarker research in Manchester

Manchester, United Kingdom, and Hilden, Germany, July 11, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a partnership with multiple organizations to support creating a global genomics campus in Manchester, U.K., for innovation, life sciences, translational science and molecular diagnostics. QIAGEN is working with Health Innovation Manchester, the partnership which brings... Read more

Bio-Techne Scales Antibody Validation Initiative Using CRISPR Gene Editing Technology Across a Broad Spectrum of Targets

 Download as PDF JULY 10, 2018 Knockout Validation of Antibodies Confirms Specificity and Ensures Reproducible Results MINNEAPOLIS, July 10, 2018 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH), a family of brands with a unique and leading portfolio of antibody-based reagents for life science and clinical research, has been validating an extensive and growing number of antibodies using... Read more

Agena Announces MassARRAY® Commercial Partnership Agreement With Dian For China Clinical Laboratory Market

San Diego, CA, July 10, 2018 – Agena Bioscience announced today that it has entered into a commercial partnership agreement with Zhejiang Dian Diagnostics Co., Ltd (“Dian”), one of China’s largest independent medical laboratories provider. The strategic agreement will enable Dian to promote and broadly commercialize Agena’s MassARRAY® System and DNA testing applications and products throughout... Read more

Pacific Biosciences Selected for NSF Project to Rapidly Sequence Maize Pangenome

MENLO PARK, Calif., July 10, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that a multi-institutional consortium of maize researchers is using the Sequel® System to create a 26-line pangenome reference collection. Led by faculty investigator R. Kelly Dawe, Distinguished... Read more

MilliporeSigma to Expand Operations in Gillingham, UK

Jul 02, 2018 Company to expand distribution centre for Life Science products to support future business growth MilliporeSigma, a leading science and technology company, today announced plans to expand its Gillingham, UK distribution centre. The €9 million investment will boost distribution capabilities for the business. Anticipated to open in early 2019, the new facility will... Read more

Life Sciences Industry Veteran Todd R. Nelson Named SGI-DNA CEO to Lead Spin-out from Synthetic Genomics

LA JOLLA, CA — July 2, 2018 —SGI-DNA, a leader in commercial DNA synthesis, today announced industry veteran Todd R. Nelson, Ph.D., MBA has been appointed Chief Executive Officer to lead the spin-out of the company from Synthetic Genomics, Inc. (SGI). “Todd is a proven life sciences leader who brings a wealth of knowledge and experience... Read more

GE Healthcare and Vitrolife Partner to Improve Assisted Reproductive Technology Offerings

Zipf, Austria – June 28, 2018 – In the lead up to the European Society of Human Reproduction and Embryology (ESHRE) annual conference, GE Healthcare and Vitrolife are partnering to improve patient outcomes in assisted reproductive medicine.  Infertility is a growing health issue that affects a significant number of women and couples around the world.... Read more

David King Joins Fluidigm as Vice President, Research and Development, Genomics

SOUTH SAN FRANCISCO, Calif., June 26, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of David King as Vice President, Research and Development, Genomics. As a member of the executive leadership team reporting to President and CEO Chris Linthwaite, King will drive R&D strategy and execution for all genomics products and systems across the company. “Fluidigm is a leader... Read more

QIAGEN announces broadening of GeneReader NGS System applications into hereditary disease analysis

Hilden, Germany, and Germantown, Maryland, June 25, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today introduced seamless next-generation sequencing (NGS) solutions for a wide range of hereditary diseases on the GeneReader NGS System, the complete Sample to Insight NGS solution for any lab worldwide. QIAGEN has launched customizable QIAact target enrichment panels... Read more

Thermo Fisher Scientific Donates Rapid DNA Analysis Technology to Help Reunite Families Recently Separated at Border

Thermo Fisher Scientific Donates Rapid DNA Analysis Technology to Help Reunite Families Recently Separated at Border Accredited technology quickly and accurately identifies parentage relationships while preserving privacy WALTHAM, Mass., June 24, 2018 /PRNewswire/ —  Thermo Fisher Scientific, the world leader in serving science, today announced it is offering to donate $1 million worth of rapid... Read more